1-13 of 13
Leo F. Verdonck, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Comparative Value of Hematopoietic Stem Cell Transplantation and Chemotherapy in Cytogenetically Normal AML Subclassified By NPM1 Mutation Status and FLT3 -ITD Allelic Ratio

Jurjen Versluis, MD, Raynier Devillier, MD, Florentien in 't Hout, MD, Wim van Putten, MSc, Markus G Manz, MD, Marie-Christianne Vekemans, MD, Martyn Ronald Schaafsma, MDPhD, Jakob R Passweg, MD, Johan Maertens, MD PhD, Jurgen H Kuball, MDPhD, Leo F. Verdonck, MD PhD, Bart J Biemond, MD, Peter J.M. Valk, PhD, Marie-Joelle Mozziconacci, MD PhD, Norbert Vey, MD PhD, Harry C Schouten, MDPhD, Edo Vellenga, MDPhD, Thomas Pabst, MD, Bob Lowenberg, MDPhD, Gert J Ossenkoppele, MD PhD, Didier Blaise, MD PhD, Gerwin A Huls, MD PhD, Jan J Cornelissen, MD PhD
Journal: Blood
Blood (2014) 124 (21): 323.
https://doi.org/10.1182/blood.V124.21.323.323
Published: 2014
Journal Articles

Poor-Risk Acute Leukemia Patients with An EBMT Low-Risk Score and An 8/8 Matched Unrelated Donor Show Excellent Survival After Hematopoietic Stem Cell Transplantation.

Tom Lodewyck, MD, Machteld Oudshoorn, PhD, Bronno van der Holt, PhD, Eefke Petersen, MD, PhD, Eric Spierings, PhD, Peter A. Von Dem Borne, MD, PhD, Anton Schattenberg, MD, PhD, Wil Allebes, PhD, Ellen Meijer, MD, PhD, Marlies Groenendijk-Sijnke, Lucia Duinhouwer, Roelof Willemze, MD, PhD, Leo F. Verdonck, MD, PhD, Bob Lowenberg, MD, PhD, Jan J. Cornelissen, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1196.
https://doi.org/10.1182/blood.V114.22.1196.1196
Published: 2009
Journal Articles

Graft-Versus-Leukemia Effect Is Equivalent in Recipients of Matched Sibling and Matched Unrelated Donor Conventional Hematopoietic Cell Transplant.

Mukta Arora, MD, MS, Steven Pavletic, MD, PhD, Claudio Anasetti, MD, John Barrett, MD, MRCP, Tao Wang, PhD, Joseph H. Antin, MD, Paolo Di Bartolomeo, MD, Brian J. Bolwell, MD, Christopher Bredeson, MD, Mitchell Cairo, MD, Robert P. Gale, MD, PhD, Sergio Giralt, MD, Theresa Hahn, MD, Gregory Hale, MD, Joerg Halter, MD, Madan Jagasia, MD, Mark R. Litzow, MD, Franco Locatelli, MD, Phillip L. McCarthy, MD, Cowan Mort, MD, Effie W. Petersdorf, MD, James Russel, MD, Gary Schiller, MD, Harry S. Schouten, MD, PhD, Martin Tallman, MD, Leo F. Verdonck, MD, Joseph Wiley, MD, John R. Wingard, MD, Mary M. Horowitz, MD, MS, Olle Ringden, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3049.
https://doi.org/10.1182/blood.V110.11.3049.3049
Published: 2007
Journal Articles

Hematopoietic Stem Cell Transplantation after Reduced Intensity Conditioning in Acute Myeloid Leukemia Patients Older Than 40 Years.

Cynthia Huisman, MD, PhD, Ellen Meijer, MD, PhD, Eefke J. Petersen, MD, PhD, Henk M. Lokhorst, MD, PhD, Leo F. Verdonck, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 5074.
https://doi.org/10.1182/blood.V110.11.5074.5074
Published: 2007
Journal Articles

Poor Outcome after Allogeneic Hematopoietic Stem Cell Transplantation for De Novo AML with Chromosome 7 Abnormalities: A Report for the ALWP of the European Group for Blood and Marrow Transplantation.

Agnes Buzyn, MD, PhD, Myriam Labopin, MD, Jurgen Finke, MD, Tapani Ruutu, MD, G. Ehninger, MD, Leo F. Verdonck, MD, Gerard Socie, MD, PhD, Roelof Willemze, MD, Karel Indrak, MD, Nigel H. Russell, MD, Vanderson Rocha, for the ALWP of the EBMT
Journal: Blood
Blood (2007) 110 (11): 325.
https://doi.org/10.1182/blood.V110.11.325.325
Published: 2007
Journal Articles

The In Vivo Impact of Human Regulatory T Cells on the Graft Versus Tumor Effect.

Tuna Mutis, MD, PhD, Henk Rozemuller, PhD, Maarten E. Emmelot, Tineke Aarts-Riemens, Vivienne Verweij, Saskia Ebeling, PhD, Leo F. Verdonck, MD, PhD, Henk Lockhorst, MD, PhD, Anton Martens, PhD
Journal: Blood
Blood (2007) 110 (11): 349.
https://doi.org/10.1182/blood.V110.11.349.349
Published: 2007
Journal Articles

Allogeneic SCT with Matched Related and Unrelated Donors for Patients (pts) with Refractory Anemia (RA): Improved Survival after Introduction of Reduced Intensity Conditioning (RIC) Regimens.

T.M. de Witte, MD, Ronald Brand, PhD, Anja van Biezen, Ghulam Mufti, MD, Tapani Ruutu, MD, Jurgen Finke, MD, Peter von dem Borne, MD, Antonin Vitek, MD, Michel Delforge, MD, Paolo E. Alessandrino, MD, Nicholas Harhalakis, MD, Nigel H. Russell, MD, Enric Carreras, MD, Leo F. Verdonck, MD, Dietger W. Niederwieser, MD
Journal: Blood
Blood (2006) 108 (11): 519.
https://doi.org/10.1182/blood.V108.11.519.519
Published: 2006
Journal Articles

Impact of Cytogenetics on Outcome of Patients with MDS or Secondary AML Undergoing Allogeneic HSCT from HLA-Identical Siblings: A Retrospective Analysis of the EBMT-CLWP.

Francesco Onida, MD, Ronald Brand, PhD, Anja van Biezen, Renee M. Barge, MD, Leo F. Verdonck, MD, Jurgen Finke, MD, Dietrich Beelen, MD, Rodrigo Martino, MD, José M. Fernandez-Ranada, MD, Dietger Niederwieser, MD, Nicolaus Kröger, MD, Theo de Witte, MD
Journal: Blood
Blood (2006) 108 (11): 2653.
https://doi.org/10.1182/blood.V108.11.2653.2653
Published: 2006
Journal Articles

Generation of CD4 + Regulatory T Cells by Retroviral Transduction of CD4 + CD25 − T Cells Either with the Full-Length or with a Common Exon-2 Negative Variant of Human Foxp3.

Tuna Mutis, MD, PhD, Leo F. Verdonck, MD, PhD, Tineke Aarts-Riemens, Maarten Emmelot
Journal: Blood
Blood (2005) 106 (11): 3315.
https://doi.org/10.1182/blood.V106.11.3315.3315
Published: 2005
Journal Articles

Induction of Xenogeneic Graft-Versus-Host Disease through Administration of HuPBMC to Immune Deficient RAG2 −/− γc −/− Mice: A Model for B Cell-Involvement in Chronic Graft-Versus-Host Disease.

Marijke C. Canninga-van Dijk, MD, PhD, Rozemarijn S. van Rijn, MD, Elles R. Simonetti, BSc, Marieke C. Hogenes, MD, Saskia Smulders, BSc, Roel A. de Weger, PhD, Anton Hagenbeek, MD, PhD, Jan G. van de Tweel, MD, PhD, Leo F. Verdonck, MD, PhD, Anton C.M. Martens, PhD, Saskia B. Ebeling, PhD
Journal: Blood
Blood (2005) 106 (11): 3099.
https://doi.org/10.1182/blood.V106.11.3099.3099
Published: 2005
Journal Articles

Six Courses of Intensified CHOP Plus G-CSF Compared to Eight Courses of Standard CHOP in Patients with Intermediate-Risk Aggressive Non-Hodgkin Lymphoma Results of a Prospective Randomized HOVON Trial.

Leo F. Verdonck, MD, PhD, Gustaaf W. van Imhoff, MD, John M.M. Raemakers, MD, PhD, Gregor Verhoef, MD, PhD, Mark H.H. Kramer, MD, PhD, Gert J. Ossenkoppele, MD, PhD, Jeanette K. Doorduijn, MD, PhD, Ine A.M.H. Meulendijks, MD, PhD, Wessel N. van Wieringen, MD, PhD, Pieter Sonneveld, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 14.
https://doi.org/10.1182/blood.V106.11.14.14
Published: 2005
Journal Articles

Pulmonary Complications after T-Cell Depleted Allogeneic Stem Cell Transplantation: Low Incidence and Strong Association with Acute GVHD.

Cynthia Huisman, MD, PhD, Hanneke M. van der Straaten, MD, Marijke R. Canninga-van Dijk, MD, Rob Fijnheer, MD, PhD, Leo F. Verdonck, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1821.
https://doi.org/10.1182/blood.V106.11.1821.1821
Published: 2005
Journal Articles

A Phase I Trial of Dose Escalating Simvastatin Combined with Chemotherapy in End-Stage Myeloma and Lymphoma.

Henk M. Lokhorst, MD, PhD, Niels van de Donk, MD, PhD, Ellen van de Spek, MD, Okke de Weerdt, MD, Rene van de Griend, MD, PhD, Shulamiet Wittebol, MD, Leo F. Verdonck, MD, PhD, Andries C. Bloem, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3458.
https://doi.org/10.1182/blood.V104.11.3458.3458
Published: 2004